Machaon Bonafede

ORCID: 0000-0001-6330-6718 · 15 papers in corpus · active 2013-2019

Study types

  • article 9
  • other 6

Condition tags

  • endometriosis 14
  • mesh:D004715 5
  • infertility 1
article 2019
Journal of managed care & specialty pharmacy ·doi:10.18553/jmcp.2019.25.5.566

BACKGROUND: Endometriosis is a painful chronic inflammatory disease caused by endometrial tissue implanting and growing outside the uterus, resulting in pelvic pain symptoms and subfertility. Treatment imposes a substantial economic burden …

other 2018
·doi:10.6084/m9.figshare.6106538.v1

Article full text The full text of this article can be found here. Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please cont…

article 2018
Advances in therapy ·doi:10.1007/s12325-018-0667-3

INTRODUCTION: The prevalence of endometriosis and the need for treatment in the USA has led to the need to explore the contemporary cost burden associated with the disease. This retrospective cohort study compared direct and indirect health…

other 2018
·doi:10.6084/m9.figshare.6106538

Article full text The full text of this article can be found here. Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please cont…

article 2017
·doi:10.1016/j.fertnstert.2017.07.291
article 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.03.020
other 2016
Journal of managed care & specialty pharmacy ·doi:10.18553/jmcp.2016.22.5.573

BACKGROUND: Endometriosis affects over 10 million women in the United States. Depot leuprolide acetate (LA), a gonadotropin-releasing hormone agonist, has been used extensively for the treatment of women with endometriosis but is associated…

article 2016
Current medical research and opinion ·doi:10.1185/03007995.2016.1159189

Objective To compare subsequent endometriosis-related surgery following initial laparoscopy among women treated with leuprolide acetate (LA) or other endometriosis therapies versus women who received no pharmacotherapy. Research design and …

other 2016
·doi:10.6084/m9.figshare.c.2678095

Objective To compare subsequent endometriosis-related surgery following initial laparoscopy among women treated with leuprolide acetate (LA) or other endometriosis therapies versus women who received no pharmacotherapy. Research design and …

article 2016

Objective To compare subsequent endometriosis-related surgery following initial laparoscopy among women treated with leuprolide acetate (LA) or other endometriosis therapies versus women who received no pharmacotherapy. Research design and …

other 2016
·doi:10.6084/m9.figshare.c.2678095.v2

Objective To compare subsequent endometriosis-related surgery following initial laparoscopy among women treated with leuprolide acetate (LA) or other endometriosis therapies versus women who received no pharmacotherapy. Research design and …

other 2016
·doi:10.6084/m9.figshare.c.2678095.v1

Objective: To compare subsequent endometriosis-related surgery following initial laparoscopy among women treated with leuprolide acetate (LA) or other endometriosis therapies versus women who received no pharmacotherapy Research Design and …

article 2016
·doi:10.1016/j.fertnstert.2016.07.272
article 2016
·doi:10.1016/j.fertnstert.2016.07.772
article 2013
·doi:10.1016/j.jval.2013.03.325